Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19

Vityala, Y; Tagaev, T; Mamatov, S; Aidarov, Z; Harinath, P

Vityala, Y (corresponding author), 2-5-168 Opposite Maruthi Towers, Warangal 506001, Telangana, India.

INDIAN JOURNAL OF PHARMACOLOGY, 2021; 53 (3): 246